Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Again, why not just get the vaccine? All of them have proven that they keep people from needing to be hospitalized. It's free, easy and good for 6-12 months or so.
I never said you couldn't get Covid after getting the vaccine. It's public knowledge that you can. We were talking about it keeping you from having to be hospitalized. Perhaps you should pay closer attention to the subject matter before saying things that don't pertain to the conversation.
Well, a FREE vaccine would do the same thing. You guys are unbelievable with some of the stuff you toss out there.
I hate to burst your bubble but I know someone who was on Vascepa nearly two yrs and he got Covid. It was a pretty bad case but he did not need hospitalization.
SC rejects to hear the case. What a surprise...(eye roll)
I had a 7 figure gain in Amarin up until my last trade. Up 900k+ You have to know when to get out.
I'm up 7 figures with that stock, since you brought it up lol. I will soon be up much more. I sleep like a baby. Besides, I have many more stocks than that one and I trade a lot.
Yup, while many sit here (all in) with Amarin, others have been making a killing with many other stocks. Opportunity costs are huge in this situation.
Pre-diabetic. I'm on it because it can't hurt and can only do good. Just got checked out by my cardiologist. Echo normal and calcium cat scan was a 43. I guess I'm doing okay. Mothers father and grandfather died of heart disease.
My TG's are 75.
Sure and if your PCP writes you an off-label script, you will end up paying $196 mo with Amarins discount card. This is what I've been paying because I don't meet my insurance co's requirements to be on the drug. I have one of BCBS best plans.
This further supports my information that JT was NOT shown the door, that he left on his own accord. Just because most would like to believe he was fired does not make it true. Again, when someone is fired, you don't keep him around another 3-4 months for the transition. When someone is fired, the person being fired does not participate in the hiring of his/her replacement.
That is one huge ASSUMPTION with ZERO facts to back it up.
Imagine that! BP may not agree with all the rosy sales projections and outlooks that many have due to their confirmation bias.
Typical conspiracy nonsense.
...because it's much easier to call the judge incompetent from a biased investors view.
Focusing on things a person has absolutely no control over is a waste of ones time.
Perhaps because so many have gotten so many so called logical thoughts completely wrong.
What took so long? :). I never reach that breaking point because I will not invest in a co with poor mgt. I will sell at the FIRST sign of mgt incompetence. It saves you a lot of money. To keep hanging on will not change bad mgt. Mgt is usually not successful in spite of themselves.
Every person has a breaking point and I've finally reached mine with this management.
Incompetence in the highest degree possible.
How the f*ck do you not update your R&D page for your only drug -- to say that it was approved for REDUCE-IT indication -- in 2+ years?
I just sent them a scathing email!
Standing ovation for your post. You pretty much nailed it. What I dislike most is the typical uber bull/bully bull psychology that runs rampant on these platforms. A stock doesn't know that you own it so stop defending it like someone just insulted your mother lol. Postes said I'm an odd lot buyer. If he only knew...
Amarin is a spec play, especially now lol.
Nice to know there are level headed posters who don't post that often, out there :)
Wow, someone who actually gets it. JT's departure was planned. JT willingly stepped aside and was not forced to leave. We both know that the SH's like to believe what usually doesn't turn out to be the case due to emotions. I'm willing to bet that JT was a big part of the process in hiring the new guy. This succession plan was put into place towards the end of 2020.
Conjecture! Where's the proof that he was fired?
If not, that would be the correct thing to do.
We are talking about an FDA approved drug, not some OTC product. Fish oil smells disgusting in general.
If it was rotten, the FDA would have shut them down already. Why not look at the obvious instead of assuming the generic is rancid?
Who said it was rancid? Did you bring it to a lab for testing? Just because it smells bad doesn't mean it's rancid or even bad for that fact. Personally, I don't care for the smell of Vascepa and yes, it does have a fish odor. I've caught a whiff of plenty of OTC fish oil capsules and wanted to vomit. Did it mean they were spoiled? No
A colleague of mine is friends with JT. While I've never asked him to find out specific things, (which he would not do anyway) he is aware of a lot of stuff that he will feed me if I ask. One thing I can assure you and everyone else is that JT was not asked to resign or forced out in any way. He just decided (after many months of mulling it over) it was time to retire and start enjoying life.
"My sources tell me" sorts of junk.
All confirmation bias! Every last word. #1 reason people lose money and throw good money after bad.
6 cases in 6.8 mil doses and they pause the vaccine. You can't fix stupid. More than 6 people will die from Covid due to this pause. Talk about the CDC cutting off its nose to spite its face.
Sometimes it takes analysts longer than the astute investors to wake up. Better late than never I guess.
This will continue to be dead for for a very long time. 4's are definitely just around the corner. I just don't understand why so many continue to hold on to this one.
Wow...down 13%. Again, careful what you wish for :)
That makes a lot of sense with the stock being down 8-10%.
Wow...quite the imagination.
I believe Wodehouse will be the winner.
2.6% in premarket trading after the company announced yesterday that CEO John Thero is retiring and will be replaced by Karim Mikhail, who is head of commercial for Europe.
The shares may be partly weaker as the transition likely means that any M&A near-term is less likely, according to Jefferies analyst Michael Yee.
Okie dokie...yeah, that's what he must if been worried about.
The reason JT is seeking early retirement is that he sees a rule 60 victory and he knows the next move by retail investors will be a dismissal of management and BOD and an attempted clawback of unjustly earned compensation.
All conjecture. Incorrect conjecture at that.